The global Proton Therapy Instrument market was valued at 729.7 million US$ in 2018 and will reach 757.3 million US$ by the end of 2025, growing at a CAGR of 3.5% during 2019-2025.

Los Angeles, CA -- (SBWire) -- 07/01/2019 --Proton therapy is a type of radiation therapy. It USES a 200-ton device to shoot high-energy particles at the speed of about 2/3 of the speed of light to destroy tumor cells and rarely damage normal human tissues.The technique was first used in patients in the 1950s and perfected in the late 1970s.

In recent years, with the increasingly mature technology, proton therapy has been accepted by more and more patients in many countries and countries in the world. The district is actively preparing to construct and strive to construct proton therapy center.

Proton therapy devices in the world are mainly concentrated in the United States, Japan, Europe and other regions.Affected by the purchase cost and maintenance cost, the main consumption areas are also concentrated in these areas. In addition, the application scope of proton therapy is gradually expanded. There are proton therapy centers in Australia, mainland China, South Korea, Taiwan and South Africa.

Proton therapy instrument manufacturers have obvious concentration, high threshold, and very high technical and capital requirements. The whole market is mainly dominated by IBA and varian, among which IBA alone has a cumulative market share of nearly 50%.In the future, with miniaturization and price reduction, the concentration of manufacturers is expected to gradually reduce.

Access PDF Version of this Report at: https://www.qyresearch.com/sample-form/form/1213787/global-proton-therapy-instrument-market

In terms of technology, the major proton accelerators are cyclotron and synchrotron, among which the share of synchrotron is gradually increasing.

The development prospect of the whole proton therapy instrument industry is broad, and the global order growth is obvious. In particular, a large number of hospitals or units with intention to build proton therapy centers have emerged in China in recent years, providing a large development space for manufacturers who intend to enter the field of proton therapy

The global Proton Therapy Instrument market was valued at 729.7 million US$ in 2018 and will reach 757.3 million US$ by the end of 2025, growing at a CAGR of 3.5% during 2019-2025.

This report focuses on Proton Therapy Instrument volume and value at global level, regional level and company level. From a global perspective, this report represents overall Proton Therapy Instrument market size by analyzing historical data and future prospect.

Regionally, this report categorizes the production, apparent consumption, export and import of Proton Therapy Instrument in North America, Europe, China, Japan, Southeast Asia and India.

Explore Full Report With Detailed TOC Here @ https://www.qyresearch.com/index/detail/1213787/global-proton-therapy-instrument-market

For each manufacturer covered, this report analyzes their Proton Therapy Instrument manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:

BA

Varian

Hitachi

Mevion

Sumitomo

ProNova

Segment by Regions

North America

Europe

China

Japan

Segment by Type

Synchrotron

Cyclotron

Synchrocyclotron

Linear accelerator

Segment by Application

Hosptial

Proton Treatment Center

Get Full Proton Therapy Instrument Market Report Now, Report delivery time within 24 hours @ https://www.qyresearch.com/settlement/pre/25b86219ef53102bb1c31440232b62ed,0,1,Global-Proton-Therapy-Instrument-Market-Professional-Survey-Report
About QYResearch
QYResearch established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.